Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/170656
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Companys Alemany, Júlia | - |
dc.contributor.author | Cozar, Mónica | - |
dc.contributor.author | Grinberg Vaisman, Daniel Raúl | - |
dc.contributor.author | Vilageliu i Arqués, Lluïsa | - |
dc.contributor.author | Codony Gisbert, Sandra | - |
dc.contributor.author | Vázquez Cruz, Santiago | - |
dc.contributor.author | Pallàs i Llibería, Mercè, 1964- | - |
dc.contributor.author | Griñán Ferré, Christian | - |
dc.date.accessioned | 2020-09-16T18:30:33Z | - |
dc.date.available | 2020-09-16T18:30:33Z | - |
dc.date.issued | 2020-09 | - |
dc.identifier.uri | http://hdl.handle.net/2445/170656 | - |
dc.description.abstract | Niemann-Pick type C (NPC) disease is a childhood autosomal recessive inherited rare neurodegenerative disease characterized by accumulation of cholesterol and glycosphingolipids and where the autophagy-lysosome system and inflammatory processes are implicated in the pathogenesis of the disease. We follow a novel approach to deal with NPC disease, by modulating key features of the disease such as inflammation and autophagy, through inhibition of soluble epoxide hydrolase (sEH). | ca |
dc.format.extent | 1 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | ca |
dc.relation.isformatof | Reproducció del document publicat a: https://ecnp33-ecnp.ipostersessions.com/default.aspx?s=D7-E7-A0-5B-12-E1-80-A8-97-EE-37-30-9D-AC-5E-71&guestview=true | - |
dc.relation.ispartof | Pòster presentat a: 33rd European College of Neuropsychopharmacology (ECNP) Congress. 12-15 September 2020 | - |
dc.rights | cc by-nc-nd (c) Companys Alemany, Júlia et al., 2020 | - |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/es/ | * |
dc.source | Comunicacions a congressos (Farmacologia, Toxicologia i Química Terapèutica) | - |
dc.subject.classification | Malalties de Niemann-Pick | - |
dc.subject.classification | Trastorns del metabolisme | - |
dc.subject.classification | Cognició | - |
dc.subject.other | Niemann-Pick diseases | - |
dc.subject.other | Disorders of metabolism | - |
dc.subject.other | Cognition | - |
dc.title | Pharmacological inhibition of soluble epoxide hydrolase protects cognitive impairment in a Niemann-Pick mice model | ca |
dc.type | info:eu-repo/semantics/conferenceObject | ca |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | ca |
Appears in Collections: | Comunicacions a congressos (Institut de Biomedicina (IBUB)) Comunicacions a congressos (Farmacologia, Toxicologia i Química Terapèutica) Comunicacions a congressos (Genètica, Microbiologia i Estadística) Comunicacions a congressos (Institut de Neurociències (UBNeuro)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
ECNP_companys.pdf | 1.18 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License